Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
STE	STERIS PLC	Ireland	$20.38B	98,814,035	95.00%	0.91%	Net Selling
BDX	BECTON DICKINSON & CO	United States	$69.46B	289,006,461	86.93%	0.63%	Net Selling	Net Selling
RMD	RESMED INC	United States	$32.05B	146,907,207	54.56%	4.31%	Net Selling	Net Selling
KRYS	KRYSTAL BIOTECH INC	United States	$4.53B	28,292,616	75.55%	24.45%	Net Selling	Net Selling
HSTM	HEALTHSTREAM INC	United States	$821.05M	30,397,886	69.30%	24.80%	Net Selling	Net Selling
VRTX	VERTEX PHARMACEUTICALS INC	United States	$103.36B	258,307,816	90.91%	1.48%	Net Selling	Net Selling
FTLF	FITLIFE BRANDS INC	United States	$129.21M	4,598,241	0.86%	99.14%	Net Buying
ANIP	ANI PHARMACEUTICALS INC	United States	$1.41B	21,078,986	21.94%	78.06%	Net Selling	Net Selling
CPRX	CATALYST PHARMACEUTICALS INC	United States	$1.77B	117,863,258	71.64%	16.33%	Net Buying	Net Buying
KIDS	ORTHOPEDIATRICS CORP	United States	$749.11M	23,549,496	43.14%	56.86%	Net Selling	Net Selling
VREX	VAREX IMAGING CORP	United States	$657.20M	40,000,000	98.75%	1.25%	Net Selling	Net Selling
PFE	PFIZER INC	United States	$156.42B	5,646,778,425	68.45%	0.27%	Net Selling	Net Selling
NEOG	NEOGEN CORP	United States	$2.70B	216,607,746	98.55%	1.45%	Net Buying	Net Buying
CRSP	CRISPR THERAPEUTICS AG	Switzerland	$4.42B	80,275,950	62.44%	37.56%	Net Buying	Net Buying
SY	SO-YOUNG INTERNATIONAL INC	China	$126.48M	75,422,436	11.12%	0.00%
USPH	U S PHYSICAL THERAPY INC	United States	$1.56B	15,068,426	92.04%	7.96%	Net Selling	Net Selling
CNMD	CONMED CORP	United States	$2.16B	30,800,747	97.42%	2.58%	Net Buying	Net Buying
ELV	ELEVANCE HEALTH INC	United States	$122.16B	232,417,867	89.35%	2.58%	Net Selling	Net Selling
IDXX	IDEXX LABORATORIES INC	United States	$39.30B	82,587,328	88.25%	1.69%	Net Selling	Net Selling
ENSG	ENSIGN GROUP INC	United States	$6.63B	56,923,016	60.07%	39.93%	Net Selling	Net Selling
RDY	DR REDDYS LABORATORIES LTD	India	$12.45B	166,527,876	14.05%	0.00%
FMS	FRESENIUS MEDICAL CARE AG	Germany	$12.71B	293,413,449	11.30%	0.00%
BSX	BOSTON SCIENTIFIC CORP	United States	$105.90B	1,470,179,843	90.65%	5.76%	Net Selling	Net Selling
RCM	R1 RCM INC	United States	$5.23B	420,280,234	47.62%	52.38%	Net Selling	Net Selling
AMGN	AMGEN INC	United States	$149.19B	535,918,901	76.49%	1.01%	Net Selling	Net Selling
DVA	DAVITA INC	United States	$12.47B	87,700,000	14.23%	85.77%	Net Buying	Net Buying
ATRC	ATRICURE INC	United States	$1.08B	48,382,325	75.23%	24.77%	Net Selling	Net Selling
ENZ	ENZO BIOCHEM INC	United States	$53.27M	51,225,734	31.93%	48.12%	Net Selling
TFFP	TFF PHARMACEUTICALS INC	United States	$6.22M	2,519,220	3.17%	96.83%	Net Buying
KNSA	KINIKSA PHARMACEUTICALS LTD	Bermuda	$1.37B	70,940,145	48.25%	9.83%	Net Selling	Net Selling
SPOK	SPOK HOLDINGS INC	United States	$292.55M	20,245,682	27.02%	72.98%	Net Selling	Net Selling
SOPH	SOPHIA GENETICS SA	Switzerland	$331.37M	65,230,559	26.43%	0.00%
BWAY	BRAINSWAY LTD	Israel	$96.73M	33,242,189	13.01%	0.00%
PLX	PROTALIX BIOTHERAPEUTICS INC	Israel	$84.74M	73,052,124	6.75%	93.25%	Net Buying
A	AGILENT TECHNOLOGIES INC	United States	$40.30B	293,055,284	87.43%	1.18%	Net Buying	Net Selling
SWAV	SHOCKWAVE MEDICAL INC	United States	$12.34B	37,396,816	79.54%	20.46%	Net Selling	Net Selling
ATR	APTARGROUP INC	United States	$9.67B	66,263,631	89.89%	3.67%	Net Selling	Net Selling
OCUP	OCUPHIRE PHARMA INC	United States	$45.90M	24,813,370	1.23%	98.77%	Net Buying	Net Buying
SEER	SEER INC	United States	$139.91M	64,773,180	54.70%	45.30%	Net Buying	Net Selling
JAZZ	JAZZ PHARMACEUTICALS PLC	Ireland	$6.89B	63,039,618	26.94%	73.06%	Net Selling	Net Selling
QGEN	QIAGEN NV	Netherlands	$9.56B	223,904,000	62.58%	0.00%
MIRM	MIRUM PHARMACEUTICALS INC	United States	$1.20B	47,003,329	48.94%	51.06%	Net Buying	Net Selling
LFWD	LIFEWARD LTD	Israel	$40.53M	8,497,162	8.06%	91.94%	Net Buying
UHS	UNIVERSAL HEALTH SERVICES INC	United States	$11.42B	67,221,337	85.92%	10.91%	Net Selling	Net Buying
SUPN	SUPERNUS PHARMACEUTICALS INC	United States	$1.66B	54,734,956	45.35%	54.65%	Net Selling	Net Selling
ADAG	ADAGENE INC	China	$106.32M	55,145,839	12.92%	0.00%
SNN	SMITH & NEPHEW PLC	United Kingdom	$10.73B	877,672,643	3.64%	0.00%
MEDP	MEDPACE HOLDINGS INC	United States	$12.12B	30,983,399	27.34%	72.66%	Net Selling	Net Selling
DGX	QUEST DIAGNOSTICS INC	United States	$15.15B	111,091,574	87.75%	1.76%	Net Selling	Net Selling
TMO	THERMO FISHER SCIENTIFIC INC	United States	$217.82B	381,312,268	89.26%	0.88%	Net Selling	Net Selling
THC	TENET HEALTHCARE CORP	United States	$11.62B	97,683,000	34.38%	65.62%	Net Selling	Net Selling
SYK	STRYKER CORP	United States	$124.43B	380,949,778	45.77%	54.23%	Net Selling	Net Selling
ATRI	ATRION CORP	United States	$730.24M	1,759,836	56.66%	43.34%	Net Buying	Net Selling
SHC	SOTERA HEALTH CO	United States	$3.09B	283,070,826	61.96%	38.04%	Net Selling	Net Selling
HAE	HAEMONETICS CORP	United States	$4.74B	50,786,117	97.49%	2.51%	Net Buying	Net Selling
SIBN	SI-BONE INC	United States	$599.95M	41,064,511	56.69%	43.31%	Net Selling	Net Selling
ABBV	ABBVIE INC	United States	$284.07B	1,766,473,359	70.16%	0.15%	Net Selling	Net Selling
QTRX	QUANTERIX CORP	United States	$644.04M	38,063,618	63.63%	36.37%	Net Buying	Net Selling
DBVT	DBV TECHNOLOGIES SA	France	$129.22M	96,431,770	39.10%	15.37%	Net Buying	Net Buying
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	Israel	$70.83M	11,452,672	12.49%	0.00%
SGHT	SIGHT SCIENCES INC	United States	$277.99M	49,553,371	33.61%	55.04%	Net Selling	Net Selling
IMMP	IMMUTEP LTD	Australia	$319.80M	1,188,834,559	0.17%	0.00%
NSPR	INSPIREMD INC	Israel	$47.15M	23,456,590	31.64%	68.36%	Net Buying
AXNX	AXONICS INC	United States	$3.42B	51,018,478	56.63%	43.37%	Net Selling
PRTA	PROTHENA CORP PUBLIC LTD CO	Ireland	$1.18B	53,720,455	53.06%	46.94%	Net Buying
CRON	CRONOS GROUP INC	Canada	$1.01B	381,298,853	8.71%	48.47%	Net Buying	Net Selling
VYNE	VYNE THERAPEUTICS INC	United States	$35.25M	14,098,888	23.19%	76.81%	Net Buying	Net Selling
FORA	FORIAN INC	United States	$83.74M	31,131,835	13.30%	57.67%	Net Buying	Net Selling
IDYA	IDEAYA BIOSCIENCES INC	United States	$3.09B	74,560,273	88.70%	10.03%	Net Selling	Net Selling
RNA	AVIDITY BIOSCIENCES INC	United States	$2.04B	79,719,473	82.47%	17.53%	Net Selling	Net Selling
AKLI	AKILI INC	United States	$32.11M	78,509,823	43.14%	56.86%	Net Selling	Net Selling
STVN	STEVANATO GROUP SPA	Italy	$7.92B	295,540,036	11.70%	0.00%
VTGN	VISTAGEN THERAPEUTICS INC	United States	$119.18M	27,025,209	38.92%	61.08%	Net Buying
ORMP	ORAMED PHARMACEUTICALS INC	United States	$94.81M	40,519,160	12.73%	46.50%
LPCN	LIPOCINE INC	United States	$24.98M	5,315,830	5.77%	94.23%	Net Buying
INSP	INSPIRE MEDICAL SYSTEMS INC	United States	$7.43B	29,585,104	64.70%	35.30%	Net Buying	Net Selling
GNFT	GENFIT SA	France	$174.42M	49,834,983	1.27%	0.00%
ALGS	ALIGOS THERAPEUTICS INC	United States	$64.02M	75,668,521	54.25%	45.75%	Net Buying
INM	INMED PHARMACEUTICALS INC	Canada	$1.60M	6,056,970	13.28%	11.17%	Net Buying	Net Buying
MDWD	MEDIWOUND LTD	Israel	$173.74M	9,221,764	27.28%	0.00%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	United States	$713.79M	26,915,243	87.10%	12.90%	Net Selling	Net Selling
KZR	KEZAR LIFE SCIENCES INC	United States	$62.25M	72,801,359	67.83%	21.82%	Net Buying
HYPR	HYPERFINE INC	United States	$57.06M	71,950,433	14.95%	36.66%	Net Selling	Net Selling
ACCD	ACCOLADE INC	United States	$568.87M	78,356,908	70.12%	29.88%	Net Buying	Net Selling
ALKS	ALKERMES PLC	Ireland	$4.04B	169,221,311	93.61%	6.39%	Net Selling	Net Selling
PTGX	PROTAGONIST THERAPEUTICS INC	United States	$1.49B	58,274,998	79.94%	20.06%	Net Selling	Net Selling
XCUR	EXICURE INC	United States	$4.33M	8,648,307	0.89%	99.11%	Net Selling	Net Selling
EHC	ENCOMPASS HEALTH CORP	United States	$8.40B	100,685,317	93.92%	6.08%	Net Selling	Net Selling
DHR	DANAHER CORP	United States	$182.83B	740,686,541	75.94%	24.06%	Net Selling	Net Selling
AXSM	AXSOME THERAPEUTICS INC	United States	$3.51B	47,374,375	71.00%	29.00%	Net Selling	Net Buying
FULC	FULCRUM THERAPEUTICS INC	United States	$473.80M	61,935,171	64.02%	35.98%	Net Buying	Net Buying
ZYME	ZYMEWORKS INC	Canada	$636.34M	70,704,890	61.32%	38.68%	Net Buying
OSCR	OSCAR HEALTH INC	United States	$4.16B	229,727,201	65.61%	24.85%	Net Selling	Net Selling
ITGR	INTEGER HOLDINGS CORP	United States	$3.68B	33,503,719	95.54%	4.46%	Net Selling	Net Selling
ANIX	ANIXA BIOSCIENCES INC	United States	$94.74M	31,899,800	13.83%	84.71%	Net Buying	Net Buying
ITCI	INTRA-CELLULAR THERAPIES INC	United States	$6.81B	96,807,191	78.45%	21.55%	Net Selling	Net Selling
NVO	NOVO NORDISK A S	Denmark	$559.33B	4,510,000,000	6.84%	0.00%
AGIO	AGIOS PHARMACEUTICALS INC	United States	$1.96B	56,772,966	75.09%	24.91%	Net Selling	Net Selling
NUTX	NUTEX HEALTH INC	United States	$32.00M	49,695,149	2.03%	97.97%	Net Buying
LEGN	LEGEND BIOTECH CORP	United States	$8.36B	363,822,069	23.61%	0.00%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	681	+1.42%	+6.14%	-3.49%	-18.37%	7.63x	5.99x	+15.18%	+2.53%	-35.33%	+82.13%	Strong Buy
Diagnostics & Research	66	-0.30%	+0.61%	-4.87%	-1.02%	38.60x	4.16x	-23.26%	+6.41%	+11.02%	+11.32%	Buy
Drug Manufacturers - General	17	-1.19%	+2.40%	-1.41%	+12.84%	150.35x	6.19x	+34.83%	+8.28%	+14.44%	+14.49%	Buy
Drug Manufacturers - Specialty & Generic	90	+1.59%	+5.32%	+1.77%	-3.85%	32.91x	2.15x	+12.03%	+3.10%	+5.63%	+32.23%	Strong Buy
Healthcare Plans	12	+0.29%	-1.86%	+0.23%	-1.13%	19.75x	2.90x	+19.68%	+6.05%	+14.12%	+17.07%	Buy
Health Information Services	61	+0.54%	+1.75%	-4.53%	-22.22%	76.01x	3.21x	+6.57%	+2.11%	+5.20%	+35.77%	Buy
Medical Care Facilities	51	-0.21%	+1.36%	-4.24%	+7.14%	-7.58x	4.35x	-93.45%	+6.66%	+13.90%	+18.12%	Buy
Medical Devices	154	+1.23%	+3.00%	-0.85%	-12.65%	28.83x	3.68x	+10.48%	+5.30%	+7.76%	+20.08%	Buy
Medical Distribution	9	-0.42%	-2.84%	-3.75%	+31.13%	26.33x	108.21x	-8.56%	+3.45%	+18.82%	+9.17%	Buy
Medical Instruments & Supplies	56	-0.01%	+2.38%	-0.51%	-11.81%	56.28x	3.55x	+11.50%	+7.83%	+10.34%	+20.39%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -21.7% over the past year, underperforming other healthcare stocks by -13 percentage points.

Cross Country Healthcare has an average 1 year price target of $20.40, an upside of 21.86% from Cross Country Healthcare's current stock price of $16.74.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Cross Country Healthcare, 20% have issued a Strong Buy rating, 20% have issued a Buy, 60% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the second best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock lose -0.71% over the past year, overperforming other healthcare stocks by 8 percentage points.

3. Progyny (NASDAQ:PGNY)

Progyny (NASDAQ:PGNY) is the third best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock lose -3.46% over the past year, overperforming other healthcare stocks by 5 percentage points.

Progyny has an average 1 year price target of $47.00, an upside of 46.55% from Progyny's current stock price of $32.07.

Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Progyny, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 54 percentage points higher than the healthcare sector average of 2.81%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 11.12%, which is 8 percentage points higher than the healthcare sector average of 2.81%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.65%, which is 6 percentage points higher than the healthcare sector average of 2.81%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.54% in the last day, and up 2.82% over the last week. Emergent Biosolutions was the among the top gainers in the healthcare sector, gaining 70.98% yesterday.

Emergent Biosolutions shares are trading higher after the company announced operational changes to stabilize its financial position and reported Q1 financial results.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -48.68% in the past year. It has underperformed other stocks in the healthcare sector by -40 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -41.18% in the past year. It has underperformed other stocks in the healthcare sector by -33 percentage points.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has dropped -0.71% in the past year. It has overperformed other stocks in the healthcare sector by 8 percentage points.

Are healthcare stocks a good buy now?

47.75% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 36.8% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 70.14x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.